Wenyi Zhang1, Katarzyna Piotrowska1, Bahman Chavoshan2,3, Jeanne Wallace3,4, Peter Y Liu1,3. 1. Division of Endocrinology, Department of Medicine, Harbor UCLA Medical Center and Los Angeles Biomedical Research Institute, Torrance, California. 2. Department of Internal Medicine, Dignity Health St. Mary Hospital, Long Beach, California. 3. Olive View UCLA Medical Center, Sylmar, California. 4. David Geffen School of Medicine at UCLA, Los Angeles, California.
Abstract
STUDY OBJECTIVES: Sleep is increasingly recognized to influence a growing array of physiological processes. The relationship between sleep duration and testis size, a marker of male reproductive potential, has not been studied. METHODS: This was a preliminary cross-sectional analysis of the baseline data from 92 healthy men (mean ± standard deviation, age 33 ± 6 years, body mass index [BMI] 24.7 ± 6.1 kg/m2), of whom 66 underwent at-home actigraphy and 47 underwent in-laboratory polysomnography. Sleep duration and architecture were measured by actigraphy and polysomnography, testicular volume by Prader orchidometer, total testosterone by liquid chromatography tandem mass spectrometry, free testosterone by equilibrium dialysis, and luteinizing hormone and follicle-stimulating hormone (FSH) by immunochemiluminometric assay. RESULTS: Sleep duration was correlated with testicular volume (r = .31, P = .046) and with FSH (r = -.30, P = .035), and rapid eye movement sleep was correlated with FSH (r = .44, P = .006). The significance of these findings did not change after adjustment for age and BMI, and were confirmed nonparametrically by resampling. A putative inverse U-shaped relationship between testicular volume and sleep duration was observed by polynomial regression (P = .049), but not with resampling (P = .068). CONCLUSIONS: There is a positive linear and a possible inverse U-shaped relationship between sleep duration and testis volume. Longitudinal or interventional studies manipulating sleep are required to better define causality, and ultimately to establish how much sleep is needed to maximize male reproductive potential. CLINICAL TRIAL REGISTRATION: Title: Hormonal Mechanisms of Sleep Restriction, Registry: ClinicalTrials.gov, Identifier: NCT02256865, URL: https://clinicaltrials.gov/ct2/show/NCT02256865.
STUDY OBJECTIVES: Sleep is increasingly recognized to influence a growing array of physiological processes. The relationship between sleep duration and testis size, a marker of male reproductive potential, has not been studied. METHODS: This was a preliminary cross-sectional analysis of the baseline data from 92 healthy men (mean ± standard deviation, age 33 ± 6 years, body mass index [BMI] 24.7 ± 6.1 kg/m2), of whom 66 underwent at-home actigraphy and 47 underwent in-laboratory polysomnography. Sleep duration and architecture were measured by actigraphy and polysomnography, testicular volume by Prader orchidometer, total testosterone by liquid chromatography tandem mass spectrometry, free testosterone by equilibrium dialysis, and luteinizing hormone and follicle-stimulating hormone (FSH) by immunochemiluminometric assay. RESULTS: Sleep duration was correlated with testicular volume (r = .31, P = .046) and with FSH (r = -.30, P = .035), and rapid eye movement sleep was correlated with FSH (r = .44, P = .006). The significance of these findings did not change after adjustment for age and BMI, and were confirmed nonparametrically by resampling. A putative inverse U-shaped relationship between testicular volume and sleep duration was observed by polynomial regression (P = .049), but not with resampling (P = .068). CONCLUSIONS: There is a positive linear and a possible inverse U-shaped relationship between sleep duration and testis volume. Longitudinal or interventional studies manipulating sleep are required to better define causality, and ultimately to establish how much sleep is needed to maximize male reproductive potential. CLINICAL TRIAL REGISTRATION: Title: Hormonal Mechanisms of Sleep Restriction, Registry: ClinicalTrials.gov, Identifier: NCT02256865, URL: https://clinicaltrials.gov/ct2/show/NCT02256865.
Authors: T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda Journal: Psychiatry Clin Neurosci Date: 2001-06 Impact factor: 5.188
Authors: Arlet V Nedeltcheva; Jennifer M Kilkus; Jacqueline Imperial; Dale A Schoeller; Plamen D Penev Journal: Ann Intern Med Date: 2010-10-05 Impact factor: 25.391
Authors: Arlet V Nedeltcheva; Jennifer M Kilkus; Jacqueline Imperial; Kristen Kasza; Dale A Schoeller; Plamen D Penev Journal: Am J Clin Nutr Date: 2008-12-03 Impact factor: 7.045
Authors: R J Hart; D A Doherty; R I McLachlan; M L Walls; J A Keelan; J E Dickinson; N E Skakkebaek; R J Norman; D J Handelsman Journal: Hum Reprod Date: 2015-09-25 Impact factor: 6.918
Authors: Ferdinando Fusco; Nicola Longo; Marco De Sio; Davide Arcaniolo; Giuseppe Celentano; Marco Capece; Roberto La Rocca; Francesco Mangiapia; Gianluigi Califano; Simone Morra; Carmine Turco; Gianluca Spena; Lorenzo Spirito; Giovanni Maria Fusco; Luigi Cirillo; Luigi De Luca; Luigi Napolitano; Vincenzo Mirone; Massimiliano Creta Journal: Front Endocrinol (Lausanne) Date: 2021-12-16 Impact factor: 5.555
Authors: Peter Y Liu; Darian Lawrence-Sidebottom; Katarzyna Piotrowska; Wenyi Zhang; Ali Iranmanesh; Richard J Auchus; Johannes D Veldhuis; Hans P A Van Dongen Journal: J Clin Endocrinol Metab Date: 2021-08-18 Impact factor: 5.958